News & Links

Implanting AxoGen’s Avance Nerve Graft Using a Robot for Cavernous Nerve Repair

Dr. Kevin Slawin and Dr. Tung Shu, founders of the Vanguard Urologic Institute, are the first in the U.S. to use AxoGen’s Avance nerve grafts to repair the cavernous nerves robotically. Click here to view the May 16, 2008, Business Wire release.

"Men's Health Video from The Methodist Hospital" - Interview with Kevin M. Slawin, M.D.

Introduces the importance of prostate cancer examination and PSA testing. Click here to view it. (13.8 MB, Pop-ups must be enabled)

"Love, Sex and PSA" - Interview with Kevin M. Slawin, M.D.

Dr Slawin was interviewed in parts of this informative and fascinating documentary about the dangers of prostate cancer - a disease which strikes one in every six men. Produced and underwritten by KTRK-TV, Channel 13, and by the Honor Your Father Foundation. Click here to view it. (42.4 MB, Pop-ups must be enabled)

"PSA Results Depend on the Assay" - Interview with Kevin M. Slawin, M.D.

In a recently published paper, Dr. Slawin and his team of researchers demonstrated that the manufacturer of the PSA assay used in patients has a significant effect on the results. Hear an interview with Dr. Slawin conducted by Journal Watch, an audio newsletter from the publishers of The New England Journal of Medicine.

Click here to listen to the interview. (10.3 MB, Pop-ups must be enabled)

Salvage Radiation Therapy Described on CNN and ABC World News Tonight

Both CNN and ABC World News Tonight featured Dr. Kevin Slawin on March 17, 2004. Dr. Slawin described encouraging results of a study of patients who showed signs of cancer after prostatectomy and were treated with salvage radiation therapy.

CNN - Click here to view .WMF news clip (4.2 MB)

ABC World News Tonight - Click here to view .WMF news clip. (3.3 MB)

In the News: A Patient's Best Bet

News 2 Houston, NBC's local affiliate, recently featured Dr. Kevin Slawin for his role in counseling patients with prostate cancer. Many different factors, including novel blood tests, are used to calculate accurate, personalized predictions of the likelihood of cure or disease progression with various therapies. With this information in hand, the patient is empowered to make the best decisions regarding his therapy.

Click Here to view .WMF news clip. (4.8 MB)

New Markers

KLRN, Channel 9, San Antonio. Short spot describing the new markers, TGFBeta and IL-6sR

Click Here to view .WMF clip (2.8 MB)

These clips require a media player installed on your PC that is capable of running video clips in .WMF format.

Kevin Slawin: Taking bench to bedside

BCM’s magazine, “From the Labs” discusses Dr. Slawin’s translational research program in prostate disease. Click here to read the article

• Taking bench to bedside

Dr. Slawin is interviewed by Baylor College of Medicine’s “Findings” magazine about Robotic Prostatectomy

• http://www.bcm.edu/findings/vol4/is8/06sep_n2.html

Links

• Baylor College of Medicine, Scott Department of Urology
• Online Nomogram CME
• Baylor College of Medicine
• Texas Medical Center
• The Methodist Hospital